Cipta Sarana Medika Tbk. vs Kentanix Supra International Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Kentanix Supra International Tbk. trades at Rp278 (market cap 602.87B, 37.6K 24h volume). The key difference: Kentanix Supra International Tbk. is far larger — about 3.8× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 37.6K). Which is the better fit depends on your goals.
| DKHH | KSIX | |
|---|---|---|
Market Cap | 158.12B | 602.87B |
Volume | 8.21M | 37.6K |
Lot | 82.15K | 376 |
Turnover | 515.2M | 10.45M |
Average Price | 62.72 | 277.88 |
Value | 515.2M | 10.45M |
Indicative Equilibrium Price | 63 | 278 |
Indicative Equilibrium Volume | 1.33K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Read more on KSIX →